Ryan Stidham
MD, MS, AGAF
Professor of Medicine
Mayo Clinic

Ryan Stidham is a translational scientist caring exclusively for patients with Crohn’s disease and ulcerative colitis. Ryan joined Mayo Clinic Florida in 2025 with a joint appointment in the Division of Gastroenterology and the Department of Artificial Intelligence and Informatics, where he serves as the Director of AI Clinical Partnerships. Prior to this he was a tenured Professor in both the Department of Computational Medicine & Bioinformatics and Department of Medicine where he served as the Associate Chair of Translational Research.

His research focus is technology development for improving disease activity measurement, clinical trial endpoint development, and automating care in IBD. Dr. Stidham’s research team has been supported by the National Institutes of Health, the Department of Defense, the National Science Foundation, the Crohn’s and Colitis Foundation, the Broad Foundation, the Leona Helmsley Charitable Trust, and several industry sponsored research collaborations. His team's work has been licensed by several technology companies and is being actively used in drug development.

Dr. Stidham received his medical degree from the University of Virginia School of Medicine, completed his internal medicine training at the University of Pennsylvania, and was an NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham has advanced training in medical imaging physics, signals analysis, electronic data management, and clinical research design and statistical analysis. He lives in Jacksonville, Florida with his wife Carrie and daughter Violet.

Sessions

Register

AI Update in 2026

Thursday, February 19, 2026
1:20 PM - 1:35 PM

Panel Q&A

Thursday, February 19, 2026
2:35 PM - 2:55 PM

IBD for the Dermatologist: Update

Thursday, February 19, 2026
4:55 PM - 5:10 PM

Panel Q&A

Thursday, February 19, 2026
5:10 PM - 5:25 PM

Combination therapy in IBD and TDM (Pros/Cons) with lessons for Derm/Rheum

Friday, February 20, 2026
4:45 PM - 5:00 PM

Panel Q&A

Friday, February 20, 2026
5:15 PM - 5:25 PM
Back to top